Drug & Alcohol

0 54

On behalf of the Pennsylvania Department of Corrections (DOC), the Department of Drug and Alcohol Programs (DDAP) is pleased to announce the solicitation for contractors to submit qualifications for the statewide Residential Housing and Treatment Services Invitation to Quality (ITQ). Contractors which meet the ITQ qualifications will be awarded a contract and will be eligible to respond to Requests for Quotes (RFQ) for various types of consulting services to commonwealth agencies and Local Public Procurement Units.

We encourage providers to review the Residential Housing and Treatment ITQ to determine eligibility and provide submissions by August 31, 2018. Use this link to access the Commonwealth’s Emarketplace. From here, you can search using the solicitation number 4400019622.

Lastly, if your organization is not an eligible contractor, please feel free to forward the information to appropriate organizations.

Thank you in advance for your submissions,
The Pennsylvania Department of Drug and Alcohol Programs

Rachel Kostelac | Communications Director
Department of Drug and Alcohol Programs
One Penn Center, 5th Floor
2601 N. 3rd St., Harrisburg, PA 17110
Phone: 717.547.3314 | Fax: 717.214.1939
www.ddap.pa.gov

0 77

On June 14, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced their new State Opioid Response Grant program. Under this new grant, the Department of Drug and Alcohol Programs (DDAP) is eligible to receive $53.3 Million.

The purpose of this grant program is to support evidence-based projects that:

  • Increase access to medication-assisted treatment (MAT) for opioid use disorder;
  • Target areas in which there are significant geographic or demographic gaps in treating opioid use disorder; and
  • Support expanded prevention efforts and recovery support services.

Given this unique opportunity to significantly improve Pennsylvania’s opioid treatment landscape, DDAP is soliciting large-scale, far-reaching, evidenced-based recommendations for how Pennsylvania can best utilize these funds. To submit a recommendation, please fill out this survey by July 9, 2018.

DDAP is excited to lead Pennsylvania in its efforts to improve opioid use disorder treatment. Your thoughts and comments are key to strengthening our current efforts as well as support initiatives planned for this funding. Please contact Lynn Cooper with any questions.

In preparation for the launch of Community HealthChoices (CHC) in the Southeast region, this CHC Fact Sheet explains the delivery of service coordination through the program. Under CHC, service coordination is a function of the managed care organizations (MCOs). A service coordinator is the MCO’s designated, accountable point-of-contact for each participant receiving long-term care services, their person-centered service plan, and service coordination. Therefore, the Office of Long-Term Living (OLTL) sees the service coordinators as part of the MCO under CHC.

In addition to the fact sheets, there are now short, easily digestible overview trainings on CHC that can be found here in order to increase stakeholder knowledge in anticipation of the Southeast rollout of the program.

To assist stakeholders in finding answers to questions more quickly, all FAQs have been consolidated into a single CHC Questions and Answers Document. The new document is in searchable PDF format and contains a table of contents that allows the user to easily move to different sections within the document.

The CHC Questions and Answers Document can be found on both the Participant and Provider sections of the CHC website by clicking on “View CHC Publications” or by following this link.

CONTACT: If you have any questions, please visit the CHC website or submit comments via email.

June 19, 2018
2:00 – 3:30 PM ET

Presenter: Joe Parks, MD, Medical Director, National Council for Behavioral Health

Register for free here.

The use of medications to treat mental illness and opioid and alcohol use disorders can produce life changing benefits. However, these medications also have significant side effects. Non-adherence to medications is generally more common among persons with mental disorders than individuals with physical health conditions and can negatively impact health outcomes and increase costs.

Interdisciplinary teams in integrated care settings have the opportunity to improve medication adherence among patients by incorporating shared decision making into the provider-patient relationship, using motivational interviewing to promote adherence, establishing pharmacies onsite to reduce barriers to accessing medications, and engaging family members in the treatment plan.

Join the SAMHSA-HRSA Center for Integrated Health Solutions for this webinar to review the importance of medication adherence and key recommendations for organizations to promote medication adherence.

After this webinar, participants will:

  • Better understand the impact of medication non-adherence on the individual, family, and community
  • Better understand consumers’ perspectives and concerns related to medication
  • Learn about several key recommendations to improve medication adherence
  • Hear about how one integrated care setting is successful in promoting medication adherence
  • Identify tools and resources to promote medication adherence

Please note the following:
Registration is free and closed captioning is available upon request.

The SAMHSA-HRSA Center for Integrated Health Solutions does not provide certificates of attendance or continuing education credits for webinar attendance.

The Substance Abuse and Mental Health Services Administration (SAMHSA) released a funding opportunity announcement for fiscal year 2018 Certified Community Behavioral Health Clinics (CCBHCs) Expansion Grants. SAMHSA anticipates awarding 25 eligible providers up to $2,000,000 annually to increase access to, and improve the quality of, community behavioral health services through the expansion of CCBHCs. CCBHCs and community behavioral health providers in states that participated in the CCBHC planning year are eligible to apply. These states include: AK, CA, CO, CT, IA, IL, IN, KY, MA, MD, MI, MN, MO, NC, NJ, NM, NV, NY, OK, OR, PA, RI, TX, and VA. Applications are due July 9, 2018. For a program description and details on eligibility click here. Contact RCPA Mental Health Division Director Sarah Eyster with any questions.

0 210

As you know, the Department of Drug and Alcohol Programs (DDAP) is working hard to implement the new American Society of Addiction Medicine (ASAM) criteria. Below is a brief summary of some of the plans for implementation and DDAP’s efforts to assist providers.

  1. The new deadline for having staff trained has been extended to December 31, 2018.
  2. The department is allowing ASAM trained supervisors to sign off on assessments done by staff that have not yet been trained.
  3. DDAP is encouraging SCAs and BHMCOs to help with training costs and the cost of downtime. End of the year adjustments have been mentioned most often as the method of covering these costs. DDAP is also working to ensure that if any SCAs have leftover funds, they will be directed to other counties that do not have any funds available to help providers.
  4. Providers are being permitted to use the Pennsylvania Client Placement Criteria (PCPC) until staff have received the ASAM training.
  5. The crosswalk document for ASAM/PCPC has been released, along with a new guidance document for the application of ASAM.
  6. Online training will be increasingly available after the initial transition period.
  7. DDAP is holding tight to the in-person training requirement; however, they have agreed to consider a waiver for online on a case-by-case basis. For example, if staff are part time and not able to take the in-person training due to other work commitments, online training will be considered.

From the recent RCPA D&A member survey, it was clear that extending the deadline and getting reimbursed for the costs/downtime were most important to members. RCPA will inform members if things are working as planned or not working. Please keep us posted on what is happening locally. Contact RCPA Drug & Alcohol Division Director Lynn Cooper with any questions.

0 150

The Office of Long-Term Living (OLTL) recently announced that they will be offering an “Opioid 101” webinar on Wednesday, May 30, 2018 at 1:00 pm.

This webinar will discuss the basics of opioid medications; what they are, how they work, and how substance use disorder is identified and treated. Additionally, the discussion will include current safe prescribing guidelines and alternative methods for managing chronic pain, information on how to recognize and respond to an overdose, how naloxone works, and how individuals can obtain it.

The webinar presenters include: Jordan Lewis, PhD, Public Policy Research Analyst, William Penn Fellow, Pennsylvania Department of Drug and Alcohol Programs; Mr. Tim Rader, Chief, Training Section, Pennsylvania Department of Drug and Alcohol Programs; Ms. Sarah Boateng, Executive Deputy Secretary, Pennsylvania Department of Health; Mr. Jeff Geibel, Chief, Treatment Division, Pennsylvania Department of Drug and Alcohol Programs.

To participate in this webinar, individuals are required to register using this link. A confirmation email will be sent that includes additional information about the webinar.

Questions regarding this webinar should be directed to Edward Butler via email or phone at 717-214-3718.

0 234

The Office of the National Coordinator for Health Information Technology, in collaboration with SAMHSA, has released two new fact sheets about the federal statute, 42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records (Part 2). The fact sheets were developed to help health information exchange (HIE) organizations and healthcare providers learn how Part 2 provisions can be used across different environments, including through electronic HIE mechanisms and in provider office settings. The new titles include:

Learn More About the Fact Sheets